University of Illinois at Chicago-University of Illinois Cancer Center ( Site 0063)

Chicago, Illinois 60612

1 studies enrolling now · 1 studies all time

What they study most

Prostate Cancer, Prostatic Neoplasms

Studies at this site

• A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) — Recruiting now